Skip to main content

Delayed vaccination in SA, dovish SARB, downbeat IMF

The announcement this week that South Africa is suspending the roll-out of Johnson&Johnson vaccines, on which it heavily relies, risks further delaying an already slow vaccine campaign. Meanwhile, comments by South African Reserve Bank Governor Lesetja Kganyago support our view that a tightening cycle is unlikely this year; most expect the SARB to begin hiking rates in 2021. Finally, the IMF’s recently released regional outlook for Sub-Saharan Africa shares our downbeat view on the region’s recovery prospects, but we still think growth in most countries will exceed the Fund’s expectations.

Become a client to read more

This is premium content that requires an active Capital Economics subscription to view.

Already have an account?

You may already have access to this premium content as part of a paid subscription.

Sign in to read the content in full or get details of how you can access it

Register for free

Sign up for a free account to gain:

  • Unlock additional content
  • Register for Capital Economics events
  • Receive email updates and economist-curated newsletters
  • Request a free trial of our services


Get access